Research ArticleRadiopharmacy & Adjunctive Medications
A Microdose PET Study of the Safety, Immunogenicity, Biodistribution, and Radiation Dosimetry of 18F-FB-A20FMDV2 for Imaging the Integrin αvβ6
Nicholas Keat, Julia Kenny, Keguan Chen, Mayca Onega, Nadia Garman, Robert J. Slack, Christine A. Parker, R. Thomas Lumbers, Will Hallett, Azeem Saleem, Jan Passchier and Pauline T. Lukey
Journal of Nuclear Medicine Technology June 2018, 46 (2) 136-143; DOI: https://doi.org/10.2967/jnmt.117.203547
Nicholas Keat
1Imanova Ltd., London, United Kingdom
Julia Kenny
2In Vitro In Vivo Translation, GlaxoSmithKline R&D, Ware, United Kingdom
Keguan Chen
3Immunogenicity and Clinical Immunology, GlaxoSmithKline R&D, Upper Merion, Pennsylvania
Mayca Onega
1Imanova Ltd., London, United Kingdom
Nadia Garman
4Clinical Operations, GlaxoSmithKline R&D, Stevenage, United Kingdom
Robert J. Slack
5Fibrosis Discovery Performance Unit, GlaxoSmithKline R&D, Stevenage, United Kingdom; and
Christine A. Parker
6Clinical Imaging, GlaxoSmithKline R&D, Stevenage, United Kingdom
R. Thomas Lumbers
5Fibrosis Discovery Performance Unit, GlaxoSmithKline R&D, Stevenage, United Kingdom; and
Will Hallett
1Imanova Ltd., London, United Kingdom
Azeem Saleem
1Imanova Ltd., London, United Kingdom
Jan Passchier
1Imanova Ltd., London, United Kingdom
Pauline T. Lukey
5Fibrosis Discovery Performance Unit, GlaxoSmithKline R&D, Stevenage, United Kingdom; and

Data supplements
Supplemental Data
Files in this Data Supplement:
In this issue
Journal of Nuclear Medicine Technology
Vol. 46, Issue 2
June 1, 2018
A Microdose PET Study of the Safety, Immunogenicity, Biodistribution, and Radiation Dosimetry of 18F-FB-A20FMDV2 for Imaging the Integrin αvβ6
Nicholas Keat, Julia Kenny, Keguan Chen, Mayca Onega, Nadia Garman, Robert J. Slack, Christine A. Parker, R. Thomas Lumbers, Will Hallett, Azeem Saleem, Jan Passchier, Pauline T. Lukey
Journal of Nuclear Medicine Technology Jun 2018, 46 (2) 136-143; DOI: 10.2967/jnmt.117.203547